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A b s t r a c t  
In this study the protective effect of chicory leaves hydroalcoholic extract (CIE) against acute liver 
injury induced by a single dose of acetaminophen (700 mg/kg, i.p.) was investigated in rats. The 
CIEand silymarin treatment (standard reference) were given in a dose of (100 mg/kg, p.o.) for 3 days 
before and at 1 and 12 h following acetaminophen administration. Treatment with CIE significantly 
reduced the levels of serum ALT, AST, alkaline phosphatase, bilirubin, total cholesterol, triglycerides, 
urea, creatinine, TNF-α and hepatic contents of malondialdehyde (MDA), nitric oxide, caspase-3 and 
hydroxyproline, with significant increases in serum total protein, albumin, HDL- cholesterol and 
hepatic activities of reduced glutathione (GSH), superoxide dismutase (SOD) and catalase (CAT) as 
compared with the acetaminophen group. The histopathological alterations mediated by 
acetaminophen were ameliorated by CIE. It was concluded that CIE protects rat liver against 
acetaminophen hepatotoxicity, most probably through abrogation of oxidative stress, inflammation 
and caspase-3 dependent apoptosis. 





Among vegetables, chicory (Cichoriumintybus L.), a typical 
vegetable indigenous to Europe and North and Western America, 
has gained attention for its content of phytochemicals such as 
phenolic acids (e.g. cichoric acid), flavonoids, sesquiterpene 
lactones (e.g. lactucin, lactucopicrin), oligofructose, inulin,tannins 
and anthocyanins[1,2]. Historically, chicory was grown by the 
ancient Egyptians as a medicinal plant, coffee substitute, and 
vegetable crop. To date, chicory is grown for the production of inulin 
on an industrial scale [3]. Various studies demonstrate the ability of 
different chicory parts to counteract various free radicals, as well as 
a linear correlation between phytochemical content and antioxidant 
capacity of this vegetable [4-7]. The CIE is reported to possess anti-
diabetic [8, 9], antiviral [10],anti-hyperlipidemic[11], wound healing 
[12], hepato and neuroprotective effects [11, 13]. 
Acetaminophen (N-acetyl-p-aminophenol; APAP) a widely used 
analgesic and antipyretic drug that is safe when taken at therapeutic 
dose, has become one of the most common cause of acute liver 
failure in western countries when taken at acute or cumulative 
overdose [14]. It is well documented that the toxic effects of 
acetaminophen are initiated by the formation of a reactive metabolite 
NAPQI, which under normal conditions is readily detoxified by 
conjugation with glutathione (GSH). However, acetaminophen 
overdose saturate detoxification pathways, resulting in GSH 
depletion, subsequently excess NAPQI, binds to cellular proteins 
especially in the mitochondria. The resulting mitochondrial oxidative 
stress leads to mitochondrial dysfunction, ATP depletion, increased 
MPT and nuclear DNA fragmentation, which contribute to 
hepatocellular necrosis. In addition, NAPQI can increase the 
formation of ROS such as superoxide anion, hydroxyl radical and 
hydrogen peroxide, and RNS such as peroxynitrite. Excess levels of 
ROS and RNS can attack hepatocellular macromolecules such as 
DNA, protein, and phospholipids, which lead to lipid peroxidation 
and depletion of the antioxidant enzymes causing an imbalance 
between pro-oxidants and antioxidants that further results in 
oxidative stress [15, 16]. Several studies highlight the importance of 
hepatic macrophages, so-called Kupffer cells, for initiating and 
driving the inflammatory processes following APAP-induced 
hepatotoxicity through the release of chemokines and the pro-
inflammatory mediators, such as nitric oxide (NO) and tumor 
necrosis factor-alpha (TNF-α), interleukins as well as activating 
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cells. Many of these pro-inflammatory cytokines can trigger 
hepatocyte cell death pathways and promote tissue damage [17]. 
The acetaminophen-induced hepatotoxicity serves as an example of 
the interrelationship between apoptotic and necrotic cell death and 
their common origin in mitochondrial dysfunction. There is 
increasing evidence that apoptosis plays a critical role in the 
pathogenesis of hepatic injury caused by acetaminophen [18]. It has 
been reported that APAP hepatotoxicity is caused by the 
mitochondrial apoptosis pathway and facilitated by chemokine 
CXCR2 signaling[19]. It was reported that APAP triggered the 
release of cytochrome C from mitochondria into the cytosol, 
activation of caspase-3 and degradation of DNA[20]. 
Previous studies have extensively demonstrated that antioxidants 
and anti-inflammatory agents effectively can protect against the 
acute hepatic injury induced by APAP administration. 
Cichoriumintybus presents a little investigated plant in terms of 
phytochemistry and pharmacology, most of the pharmacological 
studies on this plant document the testing of the roots and few 
studies tested the pharmacological effects of the leaves.  
Therefore, the objective of the present study is to examine possible 
protective effects of CIE against APAP-induced liver damage in an 
acute injury model. 
Material and Method 
Drugs and Chemicals  
Acetaminophen, silymarin, cremophor EL, bovine serum albumin 
(BSA), Folin-Ciocalteu's phenol, gallic acid, 1,1,-diphenyl-2-
picrylhydrazyl (DPPH) and 6-hydroxy-2,5,7,8-tetramethylchroman-
2-carboxylic acid (Trolox) were purchased from Sigma-Aldrich Inc. 
(St. Louis, MO, USA). All other chemicals used were of the highest 
grade commercially available. 
Acetaminophen was dissolved in warm saline (65◦C) and cooled to 
room temperature before intraprotenial (i.p.) injection. Silymarin 
were emulsified in a mixture of saline and 10% Cremophor EL before 
oral use. 
The dose of acetaminophen, Cichoriumintybus leaves extract, and 
silymarin were selected based on our preliminary experiments and 
in accordance with previous published literatures[21-24].. 
Sample Preparation 
The leaves of Cichoriumintybus L. were identified at the Herbarium 
of the department of Botany, Faculty of Science, Alexandria 
University. A voucher sample was deposited in the department of 
Pharmacology and Toxicology, Faculty of Pharmacy, AL-Azhar 
University, Egypt. The leaves were air-dried in shade, coarsely 
powdered and kept in air-tied containers. The powder was extracted 
twice with 70% ethanol at room temperature for 5 days each. The 
solution was filtered through a cotton wool and re-filtered using a 
Whatman filter paper. The filtrate was freeze-dried and the dried 
substance was kept in desiccators (yield 44%). The aqueous 
solution of the lyophilized powder of ethanolic extract was prepared 
immediately by dissolving in distilled water before oral administration 
to experimental animals. 
Estimation of total phenolic content(TPC)  
The phenolic content of the Cichoriumintybus L. leaves extract was 
estimated by the Folin- Ciocalteu assay according to the method of 
Wong et al (2006)[25]. A standard curve was plotted using various 
concentrations of Gallic acid and the TPC values were expressed as 
mg gallic acid equivalents/g of dry extract (mg GAE/100 g dw). 
DPPH Free Radical Scavenging Activity 
DPPH scavenging activity was measured using the method 
described by Cheng et al(2006) [26]. This assay is based on the 
determination of the concentration of DPPH methanolic solution, 
after adding the antioxidants. DPPH concentration is reduced by the 
existenceof an antioxidant at 515 nm and the absorption gradually 
disappears with time.Results were expressed as µM Trolox 
equivalent antioxidant capacity/ g dry weight (µM TEAC/ g dw) 
Animals 
Male adult Sprague–Dawley rats weighing 185 ± 15 g were obtained 
from the animal breeding laboratory (Helwan, Egypt). Animals were 
caged in sex groups, provided with standard laboratory chow and 
water ad libitum, and left to acclimatize at the animal house of the 
Faculty of Pharmacy, Al-Azhar University, Egypt for one week before 
experiments. The animals were kept in standard conditions, 
maintained at 22 ± 2◦C and 50 ± 5% relative humidity under a 12 h 
light–dark cycle. All animal studies were performed in accordance 
with the ethical guidelines for investigations in laboratory animals 
and were approved by the ethical committee of Faculty of Pharmacy, 
Cairo University and comply with the guide for the care and use of 
laboratory animals [27]. 
Experimental design  
Forty-eight male adult Sprague-Dawley rats were randomly 
allocated into sex equal groups (n=8, each); two rats from each 
group were used for histopathological examination as follows: 
Group 1: Received (normal saline, p.o.) and served as normal 
control.  
Group 2: Received silymarin in a dose of (100 mg/kg, p.o.) every 
12h for 3 days 
Group 3: Received CHE in a dose of (100 mg/kg, p.o.) every 12h for 
3 days 
Group 4: Received acetaminophen in a single dose of (700 mg/kg, 
i.p.)  
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Group 5: Pretreated with silymarin in a dose of (100 mg/kg, p.o.), 
every 12h for 3 days before and 1 and 12h after a single dose of 
acetaminophen (700 mg/kg, i.p.). 
Group 6: Pretreated with CIE in a dose of (100 mg/kg, p.o.), every 
12h for 3 days before and 1 and 12h after a single dose of 
acetaminophen (700 mg/kg, i.p.).  
Serum and Tissue Preparation 
At the end of the experiment, the animals were fasted overnight, 
blood samples were collected from the retro-orbital venous plexus, 
30 h after administration of APAP. Serum was separated from the 
clotted blood samples by centrifugation at 3000 rpm for 30 min, then 
aliquoted and stored at -20◦C until analysis. After blood collection, 
all animals were sacrificed then liver was dissected out, rinsed in 
isotonic sterile saline, blotted dry on a filter paper and weighed. 
Homogenization was carried out in ice-cold isotonic saline using 
(heidolphdiax 900 homogenizer, Germany) to yield a 10% (w/v) 
tissue homogenate. The homogenate was then made into aliquots 
and used for determination of hepatic contents of total protein, 
malondialdehyde (MDA), reduced glutathione (GSH), nitric oxide, 
hydroxyproline, caspase-3 and enzymatic activities of catalase 
(CAT), and superoxide dismutase (SOD). 
Biochemical Analysis 
Activities of serum enzymes alanine aminotransferase (ALT), 
aspartate aminotransferase (AST), alkaline phosphatase (ALP), 
total and direct bilirubin, total proteins (TP) and albumin were 
determined by colorimetric method using commercial assay kits 
(Biodiagnostics, Cairo, Egypt). In addition to , the serum levels of 
total cholesterol (TC), triglycerides (TG), high density lipoprotein 
cholesterol (HDL-C), urea and creatinine using (Diamond 
Diagnostics, Egypt) assay kits. 
Hepatic hydroxyproline and caspase-3 contents were assessed by 
employing the quantitative sandwich enzyme immunoassay 
technique using ELISA kits supplied by (Cusabio®,USA) according 
to manufacturer’s instructions. 
Tumor necrosis factor-alpha (TNF- α) was estimated in serum using 
rat TNF- α ELISA kit provided by (Alpico® diagnostics), this is a 
solid-phase sandwich ELISA utilizing a monoclonal antibody specific 
for rat TNF- α coated on a 96-well plate.  
The total protein content of hepatic tissue is determined according 
to the method of Lowry et al (1951) using BSA as standard protein 
[28]. 
Reduced glutathione (GSH) is measured according to the method of 
Beutler et al(1963) using Ellman’s reagent [5–5’ dithiobis(2-
nitrobenzoic acid) ] as a substrate [29]. The results were expressed 
as mg/g wet tissue. 
Nitric oxide concentration was determined by indirect measurement 
of nitriteconcentration, a byproduct of NO transformation in living 
tissues. The content was estimated in the liver homogenateby 
measuring the absorbance of the chromophoric azo derivative 
formed at 540 nm spectrophotometrically according to the method 
described by Miranda et al (2001) [30],the results were expressed 
as nmol/100 mg wet tissue. 
Lipid peroxidation was determined by estimating the level of 
thiobarbituric acid reactive substances (TBARSs) measured as 
malondialdehyde (MDA) According to method of Satoh [31], using 
1,1,3,3-tetraethoxypropane as a standard. The results were 
expressed as nmol of MDA/g of wet tissue. 
CAT activity was evaluated by the method of Aebi [32], which is 
based on H2O2 degradation by the action of CAT contained in the 
examined samples. Catalase activity was expressed as unit/mg 
protein. 
Activity of SOD enzyme is determined according to the method of 
Nishikimi et al (1972) [33]. Activity was expressed as U/mg protein. 
Histopathological Examination  
Samples of liver tissue from each animal were fixed in 10% neutral 
buffered formalin for 24 h, washing was done with tap water and then 
serial dilutions of ethyl alcohol were used for dehydration. 
Specimens were cleared in xylene and embedded in paraffin at 56◦C 
in hot air oven for 24 h. Paraffin wax tissue blocks were prepared for 
sectioning at 4 μm thicknesses by sledge microtone. The obtained 
tissue sections were collected on glass slides, deparaffinized, 
stained by hematoxylin and eosin stain, and examined under a light 
electric microscope by a pathologist unaware of the treatment 
protocol [34]. 
Statistical Analysis 
All values were presented as mean ± standard error of the mean 
(SEM). Statistical analysis was performed using GraphPad Prism 
version 6 (GraphPad, San Diego, CA). Comparison between 
different groups was carried out using one-way analysis of variance 
(ANOVA), followed by Tukey’stest as post hoc.  Difference was 
considered significant at p ≤ 0.05. 
Results 
Effects on cellular integrity, functional and synthetic 
capacity of hepatocytes 
Tables (1,2) show that the serum levels of ALT (193%), AST (323%), 
ALP (182%), total bilirubin (270%), and direct bilirubin 
(540%)significantly increased after administration of acetaminophen 
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Table (1): Effects of pretreatment with silymarin and CIE on serum liver enzymes, bilirubin, TP, albumin and relative body weight 
 
 
Data are expressed as means ± SEM of eight rats per group. 
aSignificantly different from the control group; bSignificantly different from the acetaminophen-treated group using one-way ANOVA followed by the Tukey test for 
multiple comparison at p ≤ 0.05. 
 
Table (2): Effects of pretreatment with silymarin and CIE on serum TC, TG, HDL-C, urea and creatinine 
 
Data are expressed as means ± SEM of eight rats per group. 
aSignificantly different from the control group; bSignificantly different from the acetaminophen-treated group using one-way ANOVA followed by the Tukey test for 
multiple comparison at p ≤ 0.05. 
Table (3): Effects of pretreatment with silymarin and CIE on hepatic content of GSH, MDA, NO, hydroxyproline, caspase-3 and liver enzymes activity 
Data are expressed as means ± SEM of eight rats per group. 
aSignificantly different from the control group; bSignificantly different from the acetaminophen-treated group;CSignificantly different from the silymarin + 
acetaminophen-treated group using one-way ANOVA followed by the Tukey test for multiple comparison at p ≤ 0.05. 
 










Scoring key: (-) none, (+) mild, (++) moderate, (+++) severe, (++++) very severe 
Foursections from each animal were examined, and were graded as follows:  - (0%), + (1-25%), ++ (26-50%), +++ (50%-75%), ++++ (>75%) 
 
Table (5): Total phenolic content and total antioxidant capacity in chicory leaves extract 
parameter Control APAP Silymarin CIE Silymarin+ APAP CIE + APAP 
ALT (U/L) 27.4 ± 2.1 80.3 ± 3.8a 22.4 ± 1.8 20.9 ± 1.3 42.5 ± 3.2a,b 41.6 ± 2.8a,b 
AST(U/L) 34.6 ± 2.2 146.3 ± 4.7a 36.1 ± 2.8 35.2 ± 2.9 58.0 ± 4.0a,b 49.1 ± 3.5b 
ALP (U/L) 116.0 ± 8.4 327.0 ± 14.6a 92.8 ± 5.7 117.0 ± 7.3 153.0 ± 8.9b 187.0 ± 9.3a,b 
Albumin (g/dl) 5.5 ± 0.34 3.9 ± 0.13a 5.5 ± 0.16 5.1 ± 0.24 4.6 ± 0.10b 4.2 ± 0.13b 
Total protein (g/dl) 8.1 ± 0.21 5.3 ± 0.24a 8.3 ± 0.27 9.2 ± 0.49b 6.1 ± 0.33b 6.5 ± 0.21b 
Total bilirubin (mg/dl) 0.84 ± 0.06 3.1 ± 0.26a 0.81 ± 0.08 0.74 ± 0.06 1.4 ± 0.11a,b 1.7 ± 0.12a,b 
Direct bilirubin (mg/dl) 0.25 ± 0.04 1.6 ± 0.15a 0.33 ± 0.04 0.20 ± 0.02 1.0 ± 0.07a,b 1.1 ± 0.08a,b 
Liver/ body weight ratio (100x) 3.0 ± 0.09 3.8 ± 0.06a 3.1 ± 0.06 3.0 ± 0.08 3.4 ± 0.09a,b 3.1 ± 0.06b 
parameter Control APAP Silymarin CIE Silymarin + APAP CIE + APAP 
Cholesterol (mg/dl) 87.8 ± 5.1 180.0 ± 5.4a 72.7 ± 5.7 92.4 ± 5.4 131.0 ± 6.2a,b 137.0 ± 4.9a,b 
Triglycerides (mg/dl) 93.9 ± 6.0 205.0 ± 10.1a 98.1 ± 4.2 102.0 ± 5.3 150.0 ± 5.4a,b 151.0 ± 4.1a,b 
HDL-C (mg/dl) 38.7 ± 2.4 24.8 ± 1.5a 45.5 ± 3.6 48.6 ± 2.9 32.2 ± 2.0b 36.1 ± 2.3b 
Urea (mg/dl) 35.9 ± 2.4 73.9 ± 5.5a 26.9 ± 1.7 29.6 ± 1.5 35.2 ± 2.0b 36.4 ± 1.9b 
Creatinine (mg/dl) 1.3 ± 0.09 3.1 ± 0.25a 1.1 ± 0.11 1.2 ± 0.09 2.0 ± 0.13a,b 2.3 ± 0.15a,b 
TNF-α (pg/ml) 35.2 ± 2.1 90.2 ± 3.1a 37.4 ± 2.4 41.2 ± 2.6 53.2 ± 3.9b 56.6 ± 3.0b 
parameter Control APAP Silymarin CIE Silymarin + APAP CIE + APAP 
GSH (mg/g. tissue ) 6.9 ± 0.63 2.4 ± 0.19a 7.2 ± 0.69 7.6 ± 0.64 6.1 ± 0.66b 6.8 ± 0.59b 
CAT (Unit/mg protein) 1.6 ± 0.11 0.7 ± 0.05a 1.4 ± 0.08 2.7 ± 0.2a 1.5 ± 0.10b 2.0 ± 0.18b,c 
SOD (Unit/mg protein) 5.3 ± 0.25 1.9 ± 0.11a 4.9 ± 0.29 5.3 ± 0.22 4.1 ± 0.19a,b 5.2 ± 0.38b,c 
MDA (nmol/g. tissue) 10.4 ± 0.57 41.1 ± 2.3 8.1 ± 0.61 7.0 ± 0.62 15.5 ± 0.65b 14.0 ± 0.69b 
NO (nmol/100 mg tissue) 44.6 ± 2.3 117.7 ± 3.8a 45.8 ± 2.2 43.8 ± 2.4 58.9 ± 2.1a,b 55.7 ± 3.1b 
Caspase-3 ( ng/g. tissue) 2.7 ± 0.25 9.7 ± 0.35a 2.9 ± 0.25 3.6 ± 0.18 4.1 ± 0.29a,b 5.1 ± 0.23a,b 
Hydroxyproline (ng/g. tissue) 2.5 ± 0.12 7.9 ± 0.33a 2.7 ± 0.18 2.9 ± 0.15 3.2 ± 0.16b 3.4 ± 0.14b 
CIE+  APAP Silymarin + APAP APAP Control Histopathological findings 
+ + ++++ - Centrolobular necrosis 
- + ++++ - Ballooning degeneration 
- + +++ - Inflammatory cell infiltration 
- ++ - - Dilatation and congestion of portal vein 
+ ++ + - Dilation of central vein 
+++ ++ + - Kuppfer cell proliferation 
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Data are expressed as means ± SD of Four determinations  
In contrast, treatment with CIE showed remarkable reductions in the 
activities of ALT, ATS, ALP, and total and direct bilirubin levels 
amounting to 48%, 66%, 43%, 45%, and 31% respectively with 
respect to acetaminophen challenged animals. Furthermore, the 
hepatotoxicity of APAP was evident from increased levels of TC, TG, 
urea and creatinineby about 195%, 117%, 106% and 138% 
respectively, accompanied by significant reductions in serum levels 
of total protein, albumin and HDL-C by about 44%, 38% and 36% 
respectively when compared to control group. On the other hand, 
treatment with CIE before and after APAP administration attenuates 
the elevated levels of TC, TG, urea and creatinine by about 24%, 
26%, 51%, and 26% respectively, and significantly increased the 
serum levels of total protein (30%), albumin (40%) and HDL-C (46%) 
comparable to APAP-treated group. 
Effects on oxidative stress markers 
Data in Table (3) showed that injection of a single dose of 
acetaminophen (700 mg/kg) produced oxidative stress manifested 
by significant increases in hepatic MDA and NO contents reaching 
295% and 164% respectively, associated with concomitant 
decreases in hepatic GSH content (66%) and the activity of 
enzymatic antioxidant parameters; SOD (64%) and CAT (56%) in 
comparison with the control group. On the other hand, treatment with 
CIE restored the normal MDA and NO contents to about 66% and 
53% respectively; associated with marked increase in hepatic GSH 
content by about 179%, meanwhile CIE administration restored the 
normal antioxidant activities of SOD (174%) or even boosted over 
the control group for CAT (186%) with respect to APAPalone 
treatment. Moreover, treatment with CIE alone significantly 
increased the activity of CAT enzyme by about 69% in comparison 
with control group. Furthermore, treatment with CIE significantly 
increased the SOD and CAT activities amounting to 27% and 34%, 
respectively with respect to the combined regimen of silymarin plus 
APAP. 
Effect on inflammation biomarker (serum level of the 
pro-inflammatory mediator; TNF-α) 
As clearly demonstrated in figure 1A, treatment with acetaminophen 
significantly increased the serum level of TNF-α to 156% in 
comparison with the control group. Such increase was significantly 
attenuated by CIE treatment to about 37% in comparison with 
acetaminophen-treated group. 
Effect on apoptosis biomarker (hepatic tissue 
content of caspase-3) 
The ELISA assay technique revealed that administration of 
acetaminophen alone was accompanied by an increase in caspase-
3 content by about 260% compared to the control group. Moreover, 
administration of CIE before and after acetaminophen showed a 
remarkable decrease in this level to about 48% as compared to 









Figure 1: Effects of pretreatment with silymarin and CIE on serum TNF-α level and hepatic caspase-3 and hydroxyproline contents. 
 
CIE Parameters 
51± 2.4 TPC (mg/g gallic acid) 
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Figure 2: Histology of liver samples of the control, APAP-treated group, silymarin + APAP group and CIE + APAP group. 
(A) Control group: normal histological structure of the central vein (CV) and surrounding hepatocytes (h); (B) Acetaminophen-treated group: severe focal 
centrolobular necrosis (n) with central pyknotic nuclei surrounded by ballooning degeneration (b) in most of hepatic parenchyma; (C) Silymarin + Acetaminophen-
treated group: dilatation in central vein with kuppfer cells proliferation (arrow) between hepatocytes; (D) Chicoricumindicum extract + Acetaminophen-treated 
group: diffuse kuppfer cells proliferation between hepatocytes. Hematoxylin–eosin staining, magnifications: ×40.m 
 
Effect on hydroxyproline content (a marker for 
collagen accumulation) 
Immunoassay technique has shown that, treatment with APAP alone 
was accompanied by an increase in hepatic hydroxyproline content 
by about 216% in comparison with the control group. Meanwhile 
treatment with CIE before and after APAP has shown a 
normalization effect on this level to about 57% when compared to 
APAP-treated group (figure 1C). 
Effect on histopathological examination 
Examination of liver sections of the control group showed normal 
architecture of the central vein and the surrounding hepatocytes 
(Figure 2A). On the other hand, histopathological analysis of the 
APAP alone treated rats showed severe focal centrilobular necrosis 
with central pyknotic nuclei surrounded by ballooning degeneration 
(Figure 2B). Treatment of the rats with silymarin (Figure 2C) 
significantly ameliorated the histological parameters induced by 
APAP.  Furthermore, liver sections of the rats pretreated with CIE 
revealed a preservation of the hepatic integrity against the 
development of histopathological damage induced by APAP (Figure 
2D).  
Discussion 
The present study provides evidence of the antihepatotoxic effect of 





 Nady et al. International Journal of Phytomedicine 8 (1) 13-21 [2016] 
 




reference drug silymarin. Increase in serum levels of ALT, AST, ALP, 
bilirubin, TC, TG, urea and creatininein addition to, the decrease in 
serum levels of total protein, albumin and HDL-C as a result of APAP 
administration are attributable to severe hepatic injury and 
dysfunction [35-37]. Treatment of rats with CIE before and after 
acetaminophen alleviated these alterations. These ameliorations 
can be reported in terms of the ability of CIE to the cell against 
oxidative insult and indicate preservation of cellular integrity and 
synthetic capacity of the liver and also suggest an anti-
hyperlipidemic effect [38, 39]. 
The protective effect of CIE can be also attributed to antioxidant 
activity, whereas the toxic effects of APAP are initiated by (NAPQI) 
metabolite, which causes GSH depletion, lipid peroxidation, and 
oxidative stress, causing an imbalance between pro-oxidants and 
antioxidants in the body [40,41]. 
GSH is the major non-enzymatic antioxidant present in all cell types 
and regulatethe intracellular redox homeostasis [42]. SOD catalyses 
the conversion of superoxide anion to O2and H2O2which further 
destroyed by CAT. Thus, the coordinate actions of various cellular 
antioxidants in cells are critical for effectively detoxifying free 
radicals. APAP administration declined hepatic antioxidant capacity 
evidenced by decreased activities of GSH, CAT, and SOD levels, 
administration of CIE restored their levels and even boosted their 
activities, preventing oxidative damage to the liver [8]. 
MDA is a secondary product of oxidative stress formed during lipid 
peroxidation which may be responsible for tissue injury [43]. In the 
present study, a significant increase in MDA content was observed 
with acetaminophen, treatment with CIE significantly decreases its 
level toward normal, and thisfindingis in agreement with previous 
reports [44, 45]. 
The role of TNF-α and NO in potentiating the liver damage produced 
by APAP administration has been demonstrated in several studies 
[46]. Our findings are in accordance with those reports. The present 
study demonstrated that CIE modulates acetaminophen-induced 
inflammation by suppressing serum level of TNF-α. In addition, CIE 
remarkably reduced in vivo generation of NO, approaching the 
control levels. 
Apoptosis plays a critical role in acetaminophen-induced hepatic 
injury, since inhibiting apoptosis prevents the development of acute 
liver failure [47]. Moreover, hepatic caspase-3 was activated in both 
wild type and CXCR2 knockout mice within one hour of APAP 
treatment[48]. Significant increase in caspase-3 activity was found 
in APAP group, while CIE treatment ameliorates this effect. To the 
best of our knowledge, this is the first demonstration of a direct effect 
of CIE on the caspase-dependent apoptotic pathway. 
 ROS have reported to inactivate collagenase and protease 
enzymes, this may decrease degradation and increase 
accumulation of collagen in hepatic tissue [49]. We estimated 
hepatic collagen content measured as hydroxyproline which used as 
indicator for tissue repair and healing process [50].Our data showed 
for the first time that acetaminophen increased hydroxyproline 
content in hepatic tissue. Moreover, our results are the first report 
showed the ameliorated effects of CIE on hydroxyproline content. 
Pretreatment with CIE also prevented hepatic necrosis; an important 
histopathological feature of APAP induced hepatotoxicity. 
In summary, CIE has proven as potential hepatoprotective agent 
similar to that of silymarin, which might be attributed to its 
antioxidant, anti-inflammatory, and caspase-dependent 
antiapoptotic activities.  
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